Stay updated on Larotrectinib in NTRK-fusion Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Larotrectinib in NTRK-fusion Solid Tumors Clinical Trial page.

Latest updates to the Larotrectinib in NTRK-fusion Solid Tumors Clinical Trial page
- Check2 days agoChange DetectedThe date has been updated from April 9, 2025, to May 13, 2025.SummaryDifference0.7%
- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.3%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page has been updated to reflect a new version release, moving from v2.14.4 to v2.15.0, and the date has changed from March 12, 2025, to April 9, 2025.SummaryDifference2%
- Check38 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for March 12, 2025. However, the deletion of the date March 25, 2025, does not significantly impact the core content.SummaryDifference0.7%
- Check60 days agoChange DetectedThe date has been updated from February 10, 2025, to March 12, 2025.SummaryDifference0.7%
- Check82 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
Stay in the know with updates to Larotrectinib in NTRK-fusion Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Larotrectinib in NTRK-fusion Solid Tumors Clinical Trial page.